Biomarkers of AKI: a Review of Mechanistic Relevance and Potential Therapeutic Implications

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2014 Aug 6

PMID 25092601

Citations 143

Authors

Joseph L Alge

John M Arthur

Affiliations

Soon will be listed here.

Abstract

AKI is a common clinical condition associated with a number of adverse outcomes. More timely diagnosis would allow for earlier intervention and could improve patient outcomes. The goal of early identification of AKI has been the primary impetus for AKI biomarker research, and has led to the discovery of numerous novel biomarkers. However, in addition to facilitating more timely intervention, AKI biomarkers can provide valuable insight into the molecular mechanisms of this complex and heterogeneous disease. Furthermore, AKI biomarkers could also function as molecular phenotyping tools that could be used to direct clinical intervention. This review highlights the major studies that have characterized the diagnostic and prognostic predictive power of these biomarkers. The mechanistic relevance of neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, IL-18, liver-type fatty acid-binding protein, angiotensinogen, tissue inhibitor of metalloproteinase-2, and IGF-binding protein 7 to the pathogenesis and pathobiology of AKI is discussed, putting these biomarkers in the context of the progressive phases of AKI. A biomarker-integrated model of AKI is proposed, which summarizes the current state of knowledge regarding the roles of these biomarkers and the molecular and cellular biology of AKI.

Citing Articles

Comparison of Effect Sevoflurane-Based Anesthesia and Propofol-Based Anesthesia on the Early Postoperative Renal Function of Living Kidney Transplant Donors: A Randomized Controlled Trial.

Cai J, Kang F, Han M, Huang X, Yan W, Wan F Drug Des Devel Ther. 2025; 19:491-503.

PMID: 39872635 PMC: 11771174. DOI: 10.2147/DDDT.S486393.

Neutrophil Gelatinase-Associated Lipocalin and Interleukin-18 in the Prediction of Acute Kidney Injury in Sepsis Patients.

Liu Y, Li C, Yang X, Guo S, Cui Z, Kang H Int J Gen Med. 2024; 17:6335-6341.

PMID: 39712197 PMC: 11663376. DOI: 10.2147/IJGM.S489826.

A Machine Learning-Based Prediction Model for Acute Kidney Injury in Patients With Community-Acquired Pneumonia: Multicenter Validation Study.

Ma M, Chen C, Chen D, Zhang H, Du X, Sun Q J Med Internet Res. 2024; 26:e51255.

PMID: 39699941 PMC: 11695953. DOI: 10.2196/51255.

Pro-Inflammatory Milieu in Human Kidney Perfusates Treated with Hypothermic Pulsatile Machine Perfusion.

Ratigan E, Kasimsetty S, Cohen J, Shigeoka A, Stocks L, Mekeel K J Oncol Res Ther. 2024; 4(1).

PMID: 39554799 PMC: 11566414.

Recent Progress in Molecular Probes for Imaging of Acute Kidney Injury.

Sitara M, Zhang W, Gao H, Li J, Tian J Chem Biomed Imaging. 2024; 2(8):526-541.

PMID: 39473990 PMC: 11503706. DOI: 10.1021/cbmi.4c00024.

References

Portilla D, Dai G, Peters J, Gonzalez F, Crew M, Proia A . Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol. 2000; 278(4):F667-75. DOI: 10.1152/ajprenal.2000.278.4.F667. View

Allred A, Chappell M, Ferrario C, Diz D . Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol. 2000; 279(4):F636-45. DOI: 10.1152/ajprenal.2000.279.4.F636. View

Hvidberg V, Jacobsen C, Strong R, Cowland J, Moestrup S, Borregaard N . The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005; 579(3):773-7. DOI: 10.1016/j.febslet.2004.12.031. View

Novick D, Kim S, Fantuzzi G, Reznikov L, Dinarello C, Rubinstein M . Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 1999; 10(1):127-36. DOI: 10.1016/s1074-7613(00)80013-8. View

Ichimura T, Hung C, Yang S, Stevens J, Bonventre J . Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2003; 286(3):F552-63. DOI: 10.1152/ajprenal.00285.2002. View

Jo S, Rosner M, Okusa M . Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol. 2007; 2(2):356-65. DOI: 10.2215/CJN.03280906. View

Silveira K, Pompermayer Bosco K, Diniz L, Carmona A, Cassali G, Bruna-Romero O . ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci (Lond). 2010; 119(9):385-94. DOI: 10.1042/CS20090554. View

Nakamura T, Sugaya T, Node K, Ueda Y, Koide H . Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006; 47(3):439-44. DOI: 10.1053/j.ajkd.2005.11.006. View

Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J . Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003; 14(10):2534-43. DOI: 10.1097/01.asn.0000088027.54400.c6. View

10.

Coca S, Garg A, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H . Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant. 2013; 28(11):2787-99. PMC: 3811062. DOI: 10.1093/ndt/gft405. View

11.

Katagiri D, Doi K, Honda K, Negishi K, Fujita T, Hisagi M . Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg. 2012; 93(2):577-83. DOI: 10.1016/j.athoracsur.2011.10.048. View

12.

Melnikov V, Ecder T, Fantuzzi G, Siegmund B, Lucia M, Dinarello C . Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001; 107(9):1145-52. PMC: 209282. DOI: 10.1172/JCI12089. View

13.

Mori K, Lee H, Rapoport D, Drexler I, Foster K, Yang J . Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115(3):610-21. PMC: 548316. DOI: 10.1172/JCI23056. View

14.

Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K . Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice. Nephrology (Carlton). 2011; 16(6):539-44. DOI: 10.1111/j.1440-1797.2011.01469.x. View

15.

Endre Z, Pickering J, Walker R, Devarajan P, Edelstein C, Bonventre J . Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011; 79(10):1119-30. PMC: 3884688. DOI: 10.1038/ki.2010.555. View

16.

Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw S, Bell M . Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17(1):R25. PMC: 4057242. DOI: 10.1186/cc12503. View

17.

Wu H, Craft M, Wang P, Wyburn K, Chen G, Ma J . IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol. 2008; 19(12):2331-41. PMC: 2588109. DOI: 10.1681/ASN.2008020170. View

18.

Seo D, Kim S, Eom S, Yoon H, Cho Y, Kim P . TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc Res. 2008; 76(3):145-51. PMC: 2574962. DOI: 10.1016/j.mvr.2008.07.003. View

19.

Barasch J, Yang J, Qiao J, Tempst P, Erdjument-Bromage H, Leung W . Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest. 1999; 103(9):1299-307. PMC: 408351. DOI: 10.1172/JCI4586. View

20.

Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A . Renal L-type fatty acid--binding protein in acute ischemic injury. J Am Soc Nephrol. 2007; 18(11):2894-902. DOI: 10.1681/ASN.2007010097. View